Linda M. Rubinstein - 16 Jul 2021 Form 4 Insider Report for BIOCEPT INC

Role
Director
Signature
/s/ Michael Nall, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
16 Jul 2021
Net transactions value
$0
Form type
4
Filing time
20 Jul 2021, 16:39:30 UTC
Next filing
09 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOC Employee Stock Option (right to buy) Award $0 +10,000 $0.000000 10,000 16 Jul 2021 Common Stock 10,000 $3.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/3 of the shares subject to the option shall vest on each of July 16, 2022 July 16, 2023, and July 16, 2024.